The contraceptives market in France has experienced a significant decline from 2012 to 2022, with the market size reducing from $587.02 million in 2012 to $44.239 million in 2022. The year-over-year variations show a consistent negative trend, with notable decreases in 2013 (-33.46%) and 2016 (-42.13%) and a dramatic drop in 2022 (-44.2%). The Compound Annual Growth Rate (CAGR) for different periods indicates a persistent downward trajectory, particularly over the last 5 years with a -24.13% CAGR.
In 2023, the market is experiencing continued contraction, reflecting ongoing challenges perhaps related to changes in consumer preferences, regulatory impacts, or competition from non-hormonal options. Future trends to watch for include advancements in non-hormonal contraceptive technologies, potential regulatory changes, and shifts in consumer health consciousness that could either mitigate or exacerbate the current decline.
How does France rank in Contraceptives (Based on Hormones or Spermicides) Market Size Value?
| # | 17 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 483,630,000 | 2023 | -0.78% | -0.58% | View data |
| 2 | 2 Argentina | 368,560,000 | 2023 | +2.14% | +3.2% | View data |
| 3 | 3 Italy | 242,670,000 | 2023 | -8.82% | -9.17% | View data |
| 4 | 4 Spain | 214,090,000 | 2023 | -11.7% | -7.16% | View data |
| 5 | 5 Chile | 123,060,000 | 2023 | -0.61% | -1.89% | View data |
| 10 | 10 New Zealand | 28,129,000 | 2023 | +2.59% | +3.2% | View data |
| 11 | 11 Guatemala | 20,869,000 | 2023 | -9.52% | -9.55% | View data |
| 12 | 12 France | 16,955,000 | 2023 | -61.67% | -36.31% | |
| 13 | 13 Slovenia | 14,356,000 | 2023 | -0.84% | -0.67% | View data |
| 14 | 14 Nicaragua | 12,896,000 | 2023 | +0.83% | +0.76% | View data |
